Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 19/20 | 0.62 |
| ▸ | CTSD | P07339 | 2/20 | 0.60 |
| ▸ | BACE2 | Q9Y5Z0 | 5/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29396146 | 0.96 | BACE1 (0.62) | BACE1CTSDBACE2 | |
| SCHEMBL29397483 | 0.93 | BACE1 (0.68) | BACE1CTSDBACE2 | |
| SCHEMBL29394515 | 0.93 | BACE1 (0.68) | BACE1CTSDBACE2 | |
| SCHEMBL29397926 | 0.93 | BACE1 (0.67) | BACE1CTSDBACE2 | |
| SCHEMBL30029172 | 0.92 | BACE1 (0.59) | BACE1CTSDBACE2 | |
| SCHEMBL32670624 | 0.91 | BACE1 (0.61) | BACE1 | |
| SCHEMBL30175896 | 0.91 | BACE1 (0.68) | BACE1CTSDBACE2 | |
| SCHEMBL31261771 | 0.90 | TFPI (0.56) | BACE1CTSDBACE2 | |
| SCHEMBL31257037 | 0.89 | BACE1 (0.60) | BACE1CTSDBACE2 | |
| SCHEMBL31672188 | 0.89 | BACE1 (0.65) | BACE1BACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4196495-A1 | EXENDIN-4 PEPTIDE ANALOGUES | TXP Pharma GmbH (CH) | 2023-06-21 | — | — | EP | claimed |
| WO-2022034062-A1 | EXENDIN-4 PEPTIDE ANALOGUES | TXP PHARMA AG (CH) | 2022-02-17 | — | — | WO | claimed |
| EP-4196495-A1 | EXENDIN-4 PEPTIDE ANALOGUES | TXP Pharma GmbH (CH) | 2023-06-21 | — | — | EP | disclosed |
| WO-2022034062-A1 | EXENDIN-4 PEPTIDE ANALOGUES | TXP PHARMA AG (CH) | 2022-02-17 | — | — | WO | disclosed |